FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

4822611000001108: Agenerase 150mg capsules (GlaxoSmithKline) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
18510701000001112 Agenerase 150mg capsules (GlaxoSmithKline) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
58230001000001119 Agenerase 150mg capsules (GlaxoSmithKline UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Agenerase 150mg capsules (GlaxoSmithKline) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Agenerase 150mg capsules (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Agenerase 150mg capsules (GlaxoSmithKline) Is a Product containing precisely amprenavir 150 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Agenerase 150mg capsules (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Agenerase 150mg capsules (GlaxoSmithKline) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Agenerase 150mg capsules (GlaxoSmithKline) Has active ingredient Amprenavir false Inferred relationship Existential restriction modifier
Agenerase 150mg capsules (GlaxoSmithKline) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Agenerase 150mg capsules (GlaxoSmithKline) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Agenerase 150mg capsules (GlaxoSmithKline) Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Agenerase 150mg capsules (GlaxoSmithKline) Is a Agenerase true Inferred relationship Existential restriction modifier
Agenerase 150mg capsules (GlaxoSmithKline) Has specific active ingredient Amprenavir true Inferred relationship Existential restriction modifier
Agenerase 150mg capsules (GlaxoSmithKline) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Agenerase 150mg capsules (GlaxoSmithKline) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Agenerase 150mg capsules (GlaxoSmithKline) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Agenerase 150mg capsules (GlaxoSmithKline) 240 capsule Is pack of False Agenerase 150mg capsules (GlaxoSmithKline) Inferred relationship Existential restriction modifier
Agenerase 150mg capsules (GlaxoSmithKline) 240 capsule Has AMP True Agenerase 150mg capsules (GlaxoSmithKline) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start